Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial #WorldCOPDDay https://t.co/cUwDYsMqrt
RT @respiratorydec: #simultaneously #inhaled #corticosteroid use and the risk of #pneumonia in #COPD https://t.co/9RhEJL7HTS
RT @respiratorydec: #simultaneously #inhaled #corticosteroid use and the risk of #pneumonia in #COPD https://t.co/9RhEJL7HTS
RT @respiratorydec: #simultaneously #inhaled #corticosteroid use and the risk of #pneumonia in #COPD https://t.co/9RhEJL7HTS
#simultaneously #inhaled #corticosteroid use and the risk of #pneumonia in #COPD
RT @RespiratoryBMC: Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the U…
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial #WorldPneumoniaDay https://t.co/cUwDYsMqrt
RT @ATS_BSHSR: Concomitant inhaled corticosteroid use and the risk of pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIF…
RT @ATS_BSHSR: Concomitant inhaled corticosteroid use and the risk of pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIF…
RT @ATS_BSHSR: Concomitant inhaled corticosteroid use and the risk of pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIF…
RT @ATS_BSHSR: Concomitant inhaled corticosteroid use and the risk of pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIF…
Concomitant inhaled corticosteroid use and the risk of pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial #pulmonary #lung https://t.co/Jza0EaAkZQ https://t.co/smSTRpzxmM
RT @LungHealthIN: New paper supports the existing evidence of an increased #pneumonia risk associated with fluticasone propionate in #COPD…
RT @LungHealthIN: New paper supports the existing evidence of an increased #pneumonia risk associated with fluticasone propionate in #COPD…
RT @LungHealthIN: New paper supports the existing evidence of an increased #pneumonia risk associated with fluticasone propionate in #COPD…
New paper supports the existing evidence of an increased #pneumonia risk associated with fluticasone propionate in #COPD patients. @RespiratoryRes https://t.co/s7RCgXsLll
RT @dipi1_con: Concomitant inhaled #Corticosteroid use and the risk of #Pneumonia in #COPD: a matched-subgroup post hoc analysis of the UP…
RT @dipi1_con: Concomitant inhaled #Corticosteroid use and the risk of #Pneumonia in #COPD: a matched-subgroup post hoc analysis of the UP…
Concomitant inhaled #Corticosteroid use and the risk of #Pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial https://t.co/HA1WhS330L @BioMedCentral #FOAMed #ECM https://t.co/LQMGxfa49l
RT @RespiratoryBMC: New article: Concomitant inhaled corticosteroid use and the risk of #pneumonia in #COPD: a matched-subgroup post hoc an…
RT @RespiratoryBMC: New article: Concomitant inhaled corticosteroid use and the risk of #pneumonia in #COPD: a matched-subgroup post hoc an…
RT @RespiratoryBMC: New article: Concomitant inhaled corticosteroid use and the risk of #pneumonia in #COPD: a matched-subgroup post hoc an…
RT @RespiratoryBMC: New article: Concomitant inhaled corticosteroid use and the risk of #pneumonia in #COPD: a matched-subgroup post hoc an…
RT @RespiratoryBMC: New article: Concomitant inhaled corticosteroid use and the risk of #pneumonia in #COPD: a matched-subgroup post hoc an…
#respiratoryresearch Concomitant inhaled corticosteroid use and the risk of pneumonia in… https://t.co/jC8t42TZQW
New article: Concomitant inhaled corticosteroid use and the risk of #pneumonia in #COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial https://t.co/cUwDYsMqrt